Scholarlink

Background <p>There are no data in the specialist literature on regional autopsy rates for COVID-19-associated deaths (COVID-aSf) or on possible differences in the reason for and performance of forensic and clinical autopsies.</p> Method <p>The death certificates of all persons who died in Munich between 17 March 2020 and 31 May 2023 were reviewed. This period begins with the first Munich COVID-aSf and covers the period of the entire corona pandemic. For the identified COVID-aSf, the corresponding autopsy certificates and reports were analyzed. Following standardized data entry, the data were anonymized and evaluated descriptively.</p> Results <p>During the study period 48,125 people died. Of these 3502 (7.3%) were COVID-aSf and 182 of these were autopsied: 62&#xa0;(34.6%) were forensically and 120 (65.4%) were clinically autopsied. The autopsy rate for COVID-aSf was therefore 5.2%. Clinical autopsies were performed almost exclusively in hospitals with their own institutes of pathology. Forensic and clinical autopsies differed in terms of gender, age distribution and place of death of the people autopsied. There were also differences in questions asked by the clients, the autopsy methods used and content of the autopsy reports.</p> Discussion <p>This study is the first to determine the autopsy rate for COVID-aSf in Germany. This renaissance of autopsy should not be limited to the time of the COVID-19 pandemic. Quality assurance within the framework of the National Autopsy Network (NATON) should be expanded to ensure a&#xa0;uniform approach in forensic medicine and pathology.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

COVID-19-Pandemie – rechtsmedizinische und klinische Obduktionen in München

  • 期刊论文

  • 发表日期：

    2025年8月13日

查看全文
  • S. Gleich,
  • D. Wohlrab,
  • M. Rudelius,
  • G. Weirich,
  • M. Graw,
  • B. Schäffer

摘要

Background

There are no data in the specialist literature on regional autopsy rates for COVID-19-associated deaths (COVID-aSf) or on possible differences in the reason for and performance of forensic and clinical autopsies.

Method

The death certificates of all persons who died in Munich between 17 March 2020 and 31 May 2023 were reviewed. This period begins with the first Munich COVID-aSf and covers the period of the entire corona pandemic. For the identified COVID-aSf, the corresponding autopsy certificates and reports were analyzed. Following standardized data entry, the data were anonymized and evaluated descriptively.

Results

During the study period 48,125 people died. Of these 3502 (7.3%) were COVID-aSf and 182 of these were autopsied: 62 (34.6%) were forensically and 120 (65.4%) were clinically autopsied. The autopsy rate for COVID-aSf was therefore 5.2%. Clinical autopsies were performed almost exclusively in hospitals with their own institutes of pathology. Forensic and clinical autopsies differed in terms of gender, age distribution and place of death of the people autopsied. There were also differences in questions asked by the clients, the autopsy methods used and content of the autopsy reports.

Discussion

This study is the first to determine the autopsy rate for COVID-aSf in Germany. This renaissance of autopsy should not be limited to the time of the COVID-19 pandemic. Quality assurance within the framework of the National Autopsy Network (NATON) should be expanded to ensure a uniform approach in forensic medicine and pathology.